✦ LIBER ✦

Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version

✍ Scribed by YASUHIRO KANEDA; TOMIKI SUMIYOSHI; RICHARD KEEFE; YASUHITO ISHIMOTO; SHUSUKE NUMATA; TETSURO OHMORI

Book ID: 108962193
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 73 KB
Volume: 61
Category: Article
ISSN: 1323-1316
DOI: 10.1111/j.1440-1819.2007.01725.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brief screening tool for mild cognitive

Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment

✍ Yoshinori Fujiwara; Hiroyuki Suzuki; Masashi Yasunaga; Mika Sugiyama; Mutsuo Iju 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 785 KB

The Brief Assessment of Cognition in Sch

The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population

✍ Simona Anselmetti; Sara Poletti; Elena Ermoli; Margherita Bechi; Stefano Cappa; 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 70 KB

The World Health Organization Quality of

The World Health Organization Quality of Life Scale Brief Version: a validation study in patients with schizophrenia

✍ Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 221 KB

Validation of the Japanese version of EO

Validation of the Japanese version of EORTC QLQ-CR38

✍ A. Tsunoda; N. Yasuda; K. Nakao; N. Yokoyama; T. Marumori; H. Hashimoto; M. Kusa 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 151 KB

Clinical validity of the Japanese versio

Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale

✍ Maya Kurita; Kojiro Shimozuma; Satoshi Morita; Yuki Fujiki; Kenichi Ishizawa; Hi 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 91 KB

Assessing cognitive function in clinical

Assessing cognitive function in clinical trials of schizophrenia

✍ Jennifer H. Barnett; Trevor W. Robbins; Verity C. Leeson; Barbara J. Sahakian; E 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (